Core Insights - The article highlights the transformation of chronic disease management in China through the integration of AI and smart devices, shifting from passive treatment to proactive monitoring and management [5][11]. Group 1: Smart Device Implementation - Smart devices are breaking geographical barriers, allowing quality medical resources to reach rural areas, exemplified by the distribution of smart blood pressure monitors and glucose meters in Ningxia and Jiangsu [6][12]. - In Jiangsu, a digital health platform has enabled 437 medical institutions to share data, improving prescription accuracy and reducing errors, with a prescription compliance rate of 96% [6][12]. Group 2: Technological Innovations - The introduction of dynamic monitoring technology in diabetes management allows for continuous blood glucose tracking, enhancing personalized treatment plans for patients [8][9]. - The cost of domestic blood glucose monitors has significantly decreased, making them more accessible to patients, with prices dropping from nearly 1000 yuan for imported devices to around 400 yuan for domestic models [9][10]. Group 3: Collaborative Frameworks - The article discusses the importance of multi-sector collaboration in chronic disease management, with government, healthcare providers, and enterprises working together to enhance service delivery [11][12]. - Initiatives like the "government-guided, hospital-supported, and enterprise-assisted" framework in Langfang demonstrate effective collaboration in providing free monitoring and training for diabetes management [11]. Group 4: Future Directions - The integration of AI in chronic disease management is expected to evolve, with policies promoting the establishment of intelligent health management systems and personalized health profiles for residents [11][12]. - The article emphasizes the shift towards comprehensive service models in chronic disease prevention, moving from fragmented management to a more holistic approach that benefits a larger population [12].